BSX

Jonathan Monson

Known title: VP, Global Controller and CAOCIK: 0001779170

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate. Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.

this person other insiders at BSX

Transaction History

BSX▼ Sell$500K
BSX▲ Buy$0
BSX▼ Sell$43K
BSX▲ Buy$0
BSX▼ Sell$33K
BSX▲ Buy$0
BSX▼ Sell$35K
BSX▲ Buy$0
BSX▼ Sell$59K
BSX▲ Buy$0
BSX▼ Sell$42K
BSX▲ Buy$0
BSX▼ Sell$56K
BSX▲ Buy$0
BSX▼ Sell$17K
BSX▲ Buy$0
BSX▼ Sell$27K
BSX▲ Buy$0
BSX▼ Sell$28K
BSX▲ Buy$0
BSX▼ Sell$32K
BSX▲ Buy$0
BSX▼ Sell$25K
BSX▲ Buy$0
BSX▼ Sell$18K
BSX▲ Buy$64K
BSX▼ Sell$250K
BSX▼ Sell$233K
BSX▲ Buy$64K
BSX▲ Buy$0
BSX▼ Sell$12K
BSX▲ Buy$0
BSX▼ Sell$12K
BSX▲ Buy$0
BSX▼ Sell$20K
BSX▲ Buy$0
BSX▼ Sell$21K
BSX▲ Buy$0
BSX▼ Sell$16K
BSX▲ Buy$0
BSX▼ Sell$13K
BSX▲ Buy$0
BSX▼ Sell$8K
BSX▲ Buy$0
BSX▼ Sell$11K
BSX▲ Buy$0
BSX▼ Sell$8K
BSX▲ Buy$0
BSX▼ Sell$9K
BSX▲ Buy$0
BSX▼ Sell$15K
BSX▲ Buy$0
BSX▼ Sell$11K

We use analytics to understand how market-wall is used. No personal data is sold.